CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

MNEXSPIKE

RegulatoryapprovedMNEXSPIKEPositive
AI Analysis

Summary

MNEXSPIKE, a COVID-19 vaccine, has been approved for active immunization in individuals aged 65 and older and those 12-64 years of age. The approval expands vaccine options for coronavirus prevention in eligible populations.

Outcome Details

Approved for use in individuals 65 years of age and older, and 12 years through 64 years of age

Importance:6/10
Sentiment:
0.60
FDA approvalCOVID-19 vaccineimmunization
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on June 4, 2026 5:04 PM

Read Original